David Leverett

416 total citations
11 papers, 324 citations indexed

About

David Leverett is a scholar working on Hematology, Immunology and Infectious Diseases. According to data from OpenAlex, David Leverett has authored 11 papers receiving a total of 324 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Hematology, 4 papers in Immunology and 3 papers in Infectious Diseases. Recurrent topics in David Leverett's work include Complement system in diseases (4 papers), Hematopoietic Stem Cell Transplantation (4 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). David Leverett is often cited by papers focused on Complement system in diseases (4 papers), Hematopoietic Stem Cell Transplantation (4 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). David Leverett collaborates with scholars based in United Kingdom. David Leverett's co-authors include Michael Watts, Stuart J. Ings, David C. Linch, Stephen Mackinnon, Stephen Devereux, Anthony H. Goldstone, Amanda R. Perry, D C Linch, Marie Scully and Angela Sullivan and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

David Leverett

11 papers receiving 311 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Leverett United Kingdom 8 234 118 78 60 45 11 324
Bensinger Wi United States 12 267 1.1× 120 1.0× 60 0.8× 59 1.0× 23 0.5× 18 348
T Iseki Japan 11 195 0.8× 78 0.7× 67 0.9× 58 1.0× 62 1.4× 20 320
Yasutaka Aoyama Japan 11 138 0.6× 80 0.7× 77 1.0× 43 0.7× 44 1.0× 43 294
Geothy Chakupurakal Germany 12 156 0.7× 126 1.1× 157 2.0× 60 1.0× 53 1.2× 28 369
Gianna Maria D’Elia Italy 13 159 0.7× 128 1.1× 37 0.5× 116 1.9× 89 2.0× 33 357
Mary Horowitz United States 9 309 1.3× 149 1.3× 194 2.5× 78 1.3× 29 0.6× 17 458
Gail Abrahamson United Kingdom 9 260 1.1× 87 0.7× 43 0.6× 63 1.1× 36 0.8× 13 346
Elena V. Babenko Russia 9 195 0.8× 106 0.9× 130 1.7× 39 0.7× 54 1.2× 45 324
Seçkin Çağırgan Türkiye 9 187 0.8× 67 0.6× 41 0.5× 58 1.0× 35 0.8× 45 329
Stefano Giardino Italy 12 139 0.6× 84 0.7× 82 1.1× 29 0.5× 11 0.2× 40 324

Countries citing papers authored by David Leverett

Since Specialization
Citations

This map shows the geographic impact of David Leverett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Leverett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Leverett more than expected).

Fields of papers citing papers by David Leverett

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Leverett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Leverett. The network helps show where David Leverett may publish in the future.

Co-authorship network of co-authors of David Leverett

This figure shows the co-authorship network connecting the top 25 collaborators of David Leverett. A scholar is included among the top collaborators of David Leverett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Leverett. David Leverett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Thomas, Mari, Nishkantha Arulkumaran, Ferras Alwan, et al.. (2020). Plasma Exchange for COVID-19 Thrombo-Inflammatory Disease. Blood. 136(Supplement 1). 27–27. 1 indexed citations
2.
Arulkumaran, Nishkantha, Mari Thomas, David Brealey, et al.. (2020). Plasma exchange for COVID‐19 thrombo‐inflammatory disease. SHILAP Revista de lepidopterología. 2(1). 26–32. 24 indexed citations
3.
Putensen, Daniel, et al.. (2016). Is peripheral access for apheresis procedures underutilized in clinical practice?—A single centre experience. Journal of Clinical Apheresis. 32(6). 553–559. 21 indexed citations
4.
5.
6.
Watts, Michael, et al.. (2004). Successful Customization of Peripheral Blood Stem Cell Harvest Volume and Cell Concentration during Apheresis.. Blood. 104(11). 4992–4992. 4 indexed citations
7.
Watts, Michael, Stuart J. Ings, David Leverett, et al.. (2000). ESHAP and G-CSF is a superior blood stem cell mobilizing regimen compared to cyclophosphamide 1.5 g m−2 and G-CSF for pre-treated lymphoma patients: a matched pairs analysis of 78 patients. British Journal of Cancer. 82(2). 278–282. 46 indexed citations
8.
9.
Watts, Michael, Angela Sullivan, David Leverett, et al.. (1998). Back-up bone marrow is frequently ineffective in patients with poor peripheral-blood stem-cell mobilization.. Journal of Clinical Oncology. 16(4). 1554–1560. 49 indexed citations
10.
Watts, MJ, Aideen M. Sullivan, David Leverett, et al.. (1997). Evaluation of clinical scale CD34+ cell purification: experience of 71 immunoaffinity column procedures. Bone Marrow Transplantation. 20(2). 157–162. 28 indexed citations
11.
Watts, Mike, et al.. (1996). A comparison of ESHAP+G-CSF vs cyclophosphamide 1.5g/m(2)+G-CSF for PBSC mobilisation in pre-treated lymphoma patients: A matched pair analysis.. UCL Discovery (University College London). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bensinger Wi Breakdown of academic impact, for papers by T Iseki Breakdown of academic impact, for papers by Yasutaka Aoyama Breakdown of academic impact, for papers by Geothy Chakupurakal Breakdown of academic impact, for papers by Gianna Maria D’Elia Breakdown of academic impact, for papers by Mary Horowitz Breakdown of academic impact, for papers by Gail Abrahamson Breakdown of academic impact, for papers by Elena V. Babenko Breakdown of academic impact, for papers by Seçkin Çağırgan Breakdown of academic impact, for papers by Stefano Giardino
Rankless by CCL
2026